Chemical industry – Page 48
-
BusinessFDA warns Pfizer subsidiary over Epipen malfunctions
Manufacturer did not fully investigate reports of patients dying after auto-injector failures
-
BusinessEli Lilly to cut 3500 jobs
Company will close sites in US and China, and provide incentives for early retirement
-
ArticlePharma supply chains pick up pace
Contract suppliers are increasingly important in reducing time to market
-
BusinessAsia’s age of regulation
Safety legislation and data sharing in Asia is making progress but highlights a global challenge
-
ArticleIn-house training speeds up metabolism
Business plugs DMPK skills gap to improve drug discovery
-
ArticleThe benefits of blends
Blends are a simple way to improve productivity, efficiency and safety
-
BusinessEU investigates Bayer’s Monsanto takeover plan
Commission raises concerns over reduced competition across pesticide and seed markets
-
BusinessHurricane hammers US chemical industry
Petrochemical sites along Houston’s seaboard are offline, and flooding has caused explosions at an Arkema facility
-
BusinessMexichem to buy Netafim in $1.5bn deal
Takeover brings Netafim’s smart irrigation technology that could be applied across other markets
-
BusinessUS firm fined for mishandling ammonia
Demakes will pay $130,000 to settle violations and has spent $300,000 upgrading systems
-
-
-
-
BusinessMylan settles Epipen overcharging allegations
Company will pay US Department of Justice $465m for avoiding paying rebates to government healthcare systems
-
ResearchFluorescent test strip detects deadly phosgene gas
Portable test checks for industrial gas leaks and chemical attacks
-
OpinionMake room for randomness in drug development
Setting free the dark horses sometimes beats the most rational planning
-
BusinessAirgas fined for fatal nitrogen leak at US sperm bank
$300,000 penalty for leak caused by over-pressurisation after Airgas failed to update tank safety label
-
BusinessChemical and pharma bosses quit US manufacturing council
President Trump disbands the group after multiple advisers resign in protest against his stance on racism
-
WebinarCurrent topics in bioconjugation
Insights into making bioconjugates using optimal reagents and the latest techniques to create highly active and stable complexes
-
FeatureEnvironmentally benign by design
The challenge of designing drugs with biodegradability in mind